<DOC>
	<DOCNO>NCT01075217</DOCNO>
	<brief_summary>No significant difference expect observed motion artifact , heat pain report peripheral DSA perform diagnostic and/or endovascular therapeutic purpose .</brief_summary>
	<brief_title>Isovue Peripheral Digital Subtraction Angiography ( DSA )</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>provide write informed consent ; least 18 year age ; schedule undergo peripheral DSA diagnosis and/or treatment PAOD pregnant lactate female ; know allergy one ingredients wither product ; history severe congestive heart failure ( Class IV ) ; previously enrol received investigational compound within 30 day ; history hypersensitivity iodinate contrast agent ; renal impairment eGFR &lt; 60 mL/min/1.73m2 , calculate use MDRD study equation medical condition decrease chance obtain reliable data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Peripheral arterial occlusive disease ( PAOD )</keyword>
</DOC>